Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 9, 2022
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
Fri, May 6, 2022
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
Joseph Stringer Maintained (VIR) at Strong Buy with Decreased Target to $35 on, May 6th, 2022
Joseph Stringer of Needham, Maintained "Vir Biotechnology, Inc." (VIR) at Strong Buy with Decreased Target from $45 to $35 on, May 6th, 2022.
Joseph has made no other calls on VIR in the last 4 months.
There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Joel Beatty of "Baird" Upgraded from Sell to Hold and Decreased Target to $28 on, Thursday, March 3rd, 2022
This is the rating of the analyst that currently disagrees with Joseph
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $200 on, Wednesday, March 30th, 2022
